FDA.reportPublic FDA data

Biothrax 0.1 MG/ML Injectable Suspension

RxCUI
832682
RxNorm name
Biothrax 0.1 MG/ML Injectable Suspension
Display name
Biothrax 0.1 MG/ML Injectable Suspension
Full name
Biothrax 0.1 MG/ML Injectable Suspension
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:24

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
103821BiothraxAnthrax Vaccine Adsorbed351(a)Rx2026-09-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
e0b11800-8922-11df-b3d7-0002a5d5c51bBiothrax 0.1 MG/mL Injectable Suspension [PSN] · Bacillus anthracis strain V770-NP1-R antigens 0.1 MG/ML Injectable Suspension [Biothrax] [SBD] · Biothrax 0.1 MG/ML Injectable Suspension [SY]314These highlights do not include all the information needed to use BIOTHRAX safely and effectively. See full prescribing information for BIOTHRAX. BIOTHRAX ® (Anthrax Vaccine Adsorbed) injectable suspension, for intramuscular or subcutaneous use Initial U.S. Approval: 197020260123